TAKEDA-FARMACEUTICOS PORTUGAL, LDA secures contract for Vedolizumab 108 Mg/068 Ml Sol Inj Pen 068 Ml Sc

Portugal, Jan. 9 -- Portugal based TAKEDA-FARMACEUTICOS PORTUGAL, LDA has secured contract from Unidade Local De Saude De Almada-Seixal, E.P.E. for Vedolizumab 108 Mg/068 Ml Sol Inj Pen 068 Ml Sc. The value of the contract is worth 4208860 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....